153 related articles for article (PubMed ID: 12476894)
1. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
Paczek L; Kropiewnicka HE; Senatorski G; Bartłomiejczyk I
Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
[TBL] [Abstract][Full Text] [Related]
2. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
3. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
Sato H; Iwano M; Akai Y; Kurioka H; Kubo A; Yamaguchi T; Hirata E; Kanauchi M; Dohi K
Am J Nephrol; 1998; 18(6):490-4. PubMed ID: 9845822
[TBL] [Abstract][Full Text] [Related]
4. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
6. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 in diabetic nephropathy.
Metwally SS; Mosaad YM; Nassr AA; Zaki OM
Egypt J Immunol; 2005; 12(1):103-12. PubMed ID: 16734145
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.
Rivarola EW; Moyses-Neto M; Dantas M; Da-Silva CG; Volpini R; Coimbra TM
Braz J Med Biol Res; 1999 Dec; 32(12):1525-8. PubMed ID: 10585634
[TBL] [Abstract][Full Text] [Related]
9. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
10. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.
Ellis D; Forrest KY; Erbey J; Orchard TJ
Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367
[TBL] [Abstract][Full Text] [Related]
11. Activation of transforming growth factor-beta1 in diabetic kidney disease.
Hellmich B; Schellner M; Schatz H; Pfeiffer A
Metabolism; 2000 Mar; 49(3):353-9. PubMed ID: 10726914
[TBL] [Abstract][Full Text] [Related]
12. Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial.
Siriwattanasit N; Satirapoj B; Supasyndh O
BMC Nephrol; 2021 Jun; 22(1):236. PubMed ID: 34174842
[TBL] [Abstract][Full Text] [Related]
13. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
16. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
17. [Increased urinary excretion of transforming growth factor beta and interleukin-6 in patients with diabetic nephropathy].
Królak R; Paczek L; Rogala H; Bartłomiejczyk I; Gradowska L; Korczak D; Gaciong Z
Pol Arch Med Wewn; 1996 Dec; 96(6):545-51. PubMed ID: 9139274
[TBL] [Abstract][Full Text] [Related]
18. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1 in children with diabetic nephropathy.
Sawires H; Botrous O; Aboulmagd A; Madani N; Abdelhaleem O
Pediatr Nephrol; 2019 Jan; 34(1):81-85. PubMed ID: 30136104
[TBL] [Abstract][Full Text] [Related]
20. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
Ibrahim S; Rashed L
Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
